Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Croda Plugs Offerings As Sunscreen Rule Compliance Solutions

This article was originally published in The Tan Sheet

Executive Summary

Ingredient supplier Croda promotes its Solaveil XT-40W titanium dioxide dispersion as an option for green sunscreen marketers looking to meet broad-spectrum protection requirements in FDA’s final rule for OTC sunscreens.

You may also be interested in...



Skinvisible Offers Eight-Hour Photostable Sunscreen Composition

The research and development firm now offers eight-hour photostability in formulas based on its recently patented composition. Skinvisible’s other formulas are avobenzone-based with photostability of around four hours.

Skinvisible Offers Eight-Hour Photostable Sunscreen Composition

The research and development firm now offers eight-hour photostability in formulas based on its recently patented composition. Skinvisible’s other formulas are avobenzone-based with photostability of around four hours.

FDA Strengthens Sunscreen Testing And Label Requirements

As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105474

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel